Patents by Inventor Jae Seon So

Jae Seon So has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant chimeric acetylcholine receptors and their derivatives recognized by CD4 T cells of myasthenic patients for the treatment of myasthenia gravis
    Patent number: 7777003
    Abstract: The present invention relates to recombinant acetylcholine receptor polypeptides recognized by CD4 T cells of a myasthenia gravis patient and compositions for the treatment of myasthenia gravis containing the same as an effective ingredient, more precisely, recombinant acetylcholine receptor polypeptides deficient in B cell epitope, recombinant acetylcholine polypeptides in which two or more T cell epitopes are fused, a composition for the treatment of myasthenia gravis containing the above recombinant polypeptides as an effective ingredient and a treatment method for myasthenia gravis using the composition. The composition containing one or more recombinant polypeptides above can be effectively used as a myasthenia gravis specific therapeutic agent or immunomodulator without side effects.
    Type: Grant
    Filed: May 31, 2006
    Date of Patent: August 17, 2010
    Assignee: Gwangju Institute of Science and Technology
    Inventors: Sin Hyeog Im, Hwa Joong Yi, Jae Seon So
  • Compositions For Preventing Or Treating Arthritis Comprising Lactic Acid Bacteria and Collangen As Active Ingredients
    Publication number: 20090028840
    Abstract: The present invention relates to a composition for preventing or treating arthritis, which comprises a lactic acid bacterium and collagen as major active ingredients. The present composition shows excellent prevention or treatment efficacies on arthritis of animal models. In addition, since the active ingredients used in the composition of this invention have been recognized to be safe to human, the present composition has considerable safety with enhanced immunomodulatory effect in patients with arthritis.
    Type: Application
    Filed: September 22, 2006
    Publication date: January 29, 2009
    Applicant: Gwangju Institute of Sciecne and Technology
    Inventors: Sin Hyeog Im, Jae Seon So, Hwa Joong Yi